Discover
EDIT
Editas Medicine, Inc.
3.28
2 x 2.50
2 x 4.01
bid
ask
+
0.04
1.23%
2 @ 04:48 AM
3.40 +0.12 (3.66%)
| Ytd | 60.00% | |
| 1y | 45.78% |
3.13
day range
3.48
1.66
52 week range
4.54
| Open | 3.22 | Prev Close | 3.24 | Low | 3.13 | High | 3.48 | Mkt Cap | 503.35M |
| Vol | 2.98M | Avg Vol | 2.34M | EPS | -1.14 | P/E | N/A | Forward P/E | -0.53 |
| Beta | 2.01 | Short Ratio | 6.70 | Inst. Own | 70.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 2.90 | 200-d Avg | 2.68 | 1yr Est | 3.67 |
| Income Statement | |||
| Total Revenue | 2.83M | ||
| Revenues (USD) | 2.83M | ||
| Gross Profit | 2.83M | ||
| Operating Expenses | 27.83M | ||
| Research and Development Expense | 17.60M | ||
| Selling, General and Administrative Expense | 10.23M | ||
| Operating Income | -25.00M | ||
| Interest Expense | -134.00K | ||
| Net Income | -24.98M | ||
| Net Income Common Stock | -24.98M | ||
| Net Income Common Stock (USD) | -24.98M | ||
| Consolidated Income | -24.98M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -25.12M | ||
| Earning Before Interest & Taxes (USD) | -25.12M | ||
| Weighted Average Shares | 97.88M | ||
| Weighted Average Shares Diluted | 97.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 123.65M | ||
| Cash and Equivalents (USD) | 123.65M | ||
| Trade and Non-Trade Receivables | 2.59M | ||
| Current Assets | 128.07M | ||
| Property, Plant & Equipment Net | 18.30M | ||
| Total Assets | 149.34M | ||
| Debt Current | 14.20M | ||
| Total Debt | 71.97M | ||
| Current Liabilities | 39.78M | ||
| Debt Non-Current | 57.78M | ||
| Total Liabilities | 144.93M | ||
| Accumulated Retained Earnings (Deficit) | -1.65B | ||
| Shareholders Equity | 4.41M | ||
| Shareholders Equity (USD) | 4.41M | ||
| Assets Non-Current | 21.27M | ||
| Total Debt (USD) | 71.97M | ||
| Deferred Revenue | 44.51M | ||
| Liabilities Non-Current | 105.15M | ||
| Trade and Non-Trade Payables | 4.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 483.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.00M | ||
| Capital Expenditure | 64.00K | ||
| Net Cash Flow from Investing | 64.00K | ||
| Net Cash Flow from Operations | -23.06M | ||
| Share Based Compensation | 2.10M | ||